Aurinia to Present at Cowen and Company 37th Annual Healthcare Conference
March 02 2017 - 12:12PM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today
announced that its Chief Executive Officer, Richard M. Glickman,
will present at the Cowen and Company 37th Annual Healthcare
Conference in Boston, MA on March 6, 2017 at 1:20pm ET. A webcast
will be available and can be accessed via the investor section of
the Aurinia website, www.auriniapharma.com. A replay will also be
archived on the site following the event.
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing voclosporin, an investigational drug, for
the treatment of lupus nephritis (LN), an inflammation of the
kidney caused by Systemic Lupus Erythematosus (SLE) and represents
a serious progression of SLE. The company is headquartered in
Victoria, BC and focuses its development efforts globally.
www.auriniapharma.com.
We Seek Safe Harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170302006143/en/
Aurinia Pharmaceuticals Inc.Investor & Media
Contact:Celia EconomidesHead of IR &
Communicationsceconomides@auriniapharma.com